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ABSTRACT Fungal secondary metabolites are a rich source of valuable natural
products, and genome sequencing has revealed a proliferation of predicted biosyn-
thetic gene clusters in the genomes. However, it is currently an unfeasible task to
characterize all biosynthetic gene clusters and to identify possible uses of the com-
pounds. Therefore, a rational approach is needed to identify a short list of gene
clusters responsible for producing valuable compounds. To this end, several bioac-
tive clusters include a resistance gene, which is a paralog of the target gene inhib-
ited by the compound. This mechanism can be used to identify these clusters. We
have developed the FRIGG (fungal resistance gene-directed genome mining) pipe-
line for identifying this type of biosynthetic gene cluster based on homology pat-
terns of the cluster genes. In this work, the FRIGG pipeline was run using 51 Asper-
gillus and Penicillium genomes, identifying 72 unique families of putative resistance
genes. The pipeline also identiﬁed the previously characterized resistance gene inpE
from the fellutamide B cluster, thereby validating the approach. We have success-
fully developed an approach to identify putative valuable bioactive clusters based
on a speciﬁc resistance mechanism. This approach will be highly useful as an ever-
increasing amount of genomic data becomes available; the art of identifying and se-
lecting the right clusters producing novel valuable compounds will only become
more crucial.
IMPORTANCE Species belonging to the Aspergillus genus are known to produce a
large number of secondary metabolites; some of these compounds are used as
pharmaceuticals, such as penicillin, cyclosporine, and statin. With whole-genome se-
quencing, it became apparent that the genetic potential for secondary metabolite
production is much larger than expected. As an increasing number of species are
whole-genome sequenced, thousands of secondary metabolite genes are predicted,
and the question of how to selectively identify novel bioactive compounds from this
information arises. To address this question, we have created a pipeline to predict
genes involved in the production of bioactive compounds based on a resistance
gene hypothesis approach.
KEYWORDS Aspergillus, comparative genomics, genome mining, bioactive
compounds, fungal, genomes, natural products, resistance, secondary metabolism
Fungal secondary metabolites are a rich source of bioactive compounds, includingimportant pharmaceuticals such as penicillin, cyclosporine, and statins (1). When
the ﬁrst fungal genomes were sequenced, it became clear that the genomes harbor a
higher number of predicted secondary metabolite gene clusters than the number of
characterized secondary metabolites, thus revealing a much larger potential (1–4). The
number of sequenced fungal genomes is ever increasing, mainly due to large sequenc-
ing efforts such as the 1000 Fungal Genomes Project (http://1000.fungalgenomes.org/
home/) and the 300 Aspergillus genome project (5, 6), and, with them, the number of
new biosynthetic gene clusters (clusters).
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Despite progress in molecular tools and methods for characterization of such
clusters, it is still a time-consuming task, making it unfeasible to investigate all pre-
dicted clusters. Therefore, only a small fraction of the clusters is characterized and
investigated experimentally. With the plethora of clusters and the aim of discovering
novel bioactive compounds useful as drugs, the following question emerges: How do
we directly select the most interesting clusters producing potential fungicides, anti-
cancer drugs, and antimicrobial compounds? To meet this need, we have created the
“fungal resistance gene-directed genome mining” (FRIGG) pipeline to identify clusters
producing likely bioactive compounds. Appropriately for a predictive algorithm, Frigg
is the Norse goddess of foresight and wisdom.
Many bioactive compounds are toxic compounds that also impair the organisms
that synthesize them by inhibiting essential functions; therefore, a self-resistance
mechanism is needed in order for the organism to survive (7–9). One known self-
resistance mechanism is the duplication of the target gene, where the duplicate is
resistant to the compound. This second resistant version is most often located as part
of the biosynthetic gene cluster producing the toxic compound. This mechanism has
been seen in several bacterial instances, such as novobiocin (10) and pentalenolactone
(11, 12), and more recently in fungi. Mycophenolic acid (MPA) is produced by Penicillium
brevicompactum, where it inhibits IMP dehydrogenase (IMPDH), the rate-limiting step in
guanine synthesis. The biosynthetic cluster of MPA revealed an additional copy of
IMPDH (Fig. 1A), which is insensitive to MPA, thus conferring resistance (13–15).
Another example is fellutamide B, a proteasome inhibitor produced by Aspergillus
nidulans. Within the biosynthetic gene cluster, a gene (inpE) encodes a proteasome
subunit (Fig. 1B), and it was shown that this gene confers resistance (16).
An illustration of the general mechanism can be seen in Fig. 1C: two versions of an
enzyme are present. One version (the target) is affected by the secondary metabolite,
whereas the other version (the resistance gene) is not inhibited by the secondary
metabolite. Even though only a few examples of this mechanism have been veriﬁed in
ﬁlamentous fungi so far (13, 16–18), it is possible that this resistance mechanism is more
widely distributed. We thus developed the FRIGG pipeline for identifying putative
bioactive clusters with resistance genes. The aim of the pipeline is to identify bioactive
FIG 1 Resistance mechanism. (A) Mycophenolic acid chemical structure and biosynthetic cluster with the
known resistance gene mpaF (highlighted in red), which is an IMP dehydrogenase (IMPDH) inhibitor. (B)
Chemical structure of fellutamide B and overview of the biosynthetic cluster, including the resistance
gene inpE (highlighted in red), which is a proteasome inhibitor. (C) Illustration of the resistance
mechanism used by some toxin producers. The secondary metabolite is a toxin which inhibits an
essential enzyme, the target of the compound. Within the cluster responsible for producing the toxin, a
copy of the target gene is found; this version is still functioning despite the compound’s presence and
hence makes the organism self-resistant.
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clusters in a targeted manner, thus providing a way of selecting the most interesting
predicted clusters producing potential valuable drugs from whole-genome sequences.
We also note that a similar approach has been successful in bacterial genomes (30).
The immediate advantage of the FRIGG pipeline is the direct identiﬁcation of
clusters with a high likelihood of coding for useful bioactive compounds. Another major
advantage is that the target of the compound, and, hence, the mode of action, is
inherently known. Knowing the target saves a lot of time since linking the compound
to the target is extremely difﬁcult and time-consuming. Furthermore, several regular
drug discovery steps can be eliminated, since possible uses of the compound are
known from the beginning, allowing a direct route to testing for likely modes of action.
RESULTS
Pipeline development and input data. As a starting point, we were interested in
creating a pipeline for identifying clusters containing possible resistance genes from
whole-genome sequencing data. In order to do this, we based the pipeline on the
assumption that the resistance gene is found within a cluster and is a copy, a paralog,
of an essential gene found elsewhere in the genome.
For testing, we used published complete and draft-quality fungal genome se-
quences. The input for the pipeline was chosen to be three different types of data
derived from the genome sequence data: (i) predicted genes/proteins and functionally
annotated proteins (for functional annotation, we used InterPro [19, 20]), (ii) predictions
of secondary metabolite gene clusters (for this purpose, we used a reimplementation
of the fungus-optimized SMURF algorithm [21], as described previously by Vesth et al.
[6]), and (iii) groups of homologous protein sequences (we used a pipeline designed for
Aspergillus data, creating homologous protein families based on single linkages of
bidirectional BLASTp hits [as described in reference 6]). It is assumed that proteins with
similar, although not necessarily identical, functions will be clustered into the same
protein family. For our purpose, this is useful, as resistance and target genes will be
grouped into one family.
As an extensive test data set, we used 51 Penicillium and Aspergillus species
containing a total of 3,276 predicted clusters and 26,551 secondary metabolite genes.
In order to identify the most likely candidate clusters containing potential resistance
genes, the pipeline includes a number of ﬁltration steps (Fig. 2). Several of these are
designed to deal with and/or minimize the effect of possible errors in assembly and
annotation due to either inherent errors in sequencing technologies and predictions or
errors caused by the assembly and sequence quality of draft genomes. Instead of
attempting to correct these errors in the sequence or annotation, we attempt to
mitigate their effect by creating ﬁltering steps. Besides mitigating annotation and
sequencing errors, the ﬁltering steps are also implemented to deal with biological
diversity and differences.
The strategy of the pipeline is thus to identify clusters containing resistance genes,
assuming that the resistance genes are copies of essential genes. In this context, an
essential gene is deﬁned as a gene that has homologs in all the species included in the
analysis.
Steps 1 and 2: identiﬁcation of the number of homologs for cluster genes. The
ﬁrst step in the pipeline is to couple precomputed homolog protein families to the
predicted cluster genes (Fig. 2, step 1). Following this, the number of homologs,
the homology count, for each secondary metabolite gene in each organism/genome is
identiﬁed. In addition, the numbers of homologs found in predicted clusters are
recorded.
Next, clusters with potential resistance genes are selected based on a speciﬁc
pattern of homology counts (Fig. 2, step 2). In this step, the user can select various
levels of stringency for the selection pattern.
The most strict and simple selection pattern (Fig. 2, step 2, left) identiﬁes clusters
where only one of the genes has a homolog in the genome. It can have only one such
homolog, and this homolog must not be part of another cluster. The gene with the
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FIG 2 Overview of the pipeline illustrating the initial data of predicted secondary metabolite gene clusters and homologous protein
families. In step 1, the initial data are combined to generate counts of how many homologs are found in each organisms and how
many are within predicted clusters. In step 2, clusters are selected based on speciﬁc homology count patterns, either “strict,” where
only one gene can have a homolog outside the cluster, or “alternative,” where genes belonging to large protein families are allowed.
Step 3 is ﬁltering of the selected clusters based on other clusters having a homologous resistance gene; this step is optional. In step
4, ﬁltering based on the majority of the organisms should provide a homolog of the resistance/target genes. Step 5 is ﬁltering based
on the number of organism that should have only a single homolog.
Kjærbølling et al.
July/August 2019 Volume 4 Issue 4 e00085-19 msystems.asm.org 4
 o
n
 Septem
ber 18, 2019 at DTU Library
http://m
system
s.asm
.org/
D
ow
nloaded from
 
homolog in the cluster is the presumed resistance gene, and the homolog outside the
cluster is the presumed target gene. Using this selection criterion on our test data set
(see Table S1 in the supplemental material, which includes GenBank accession num-
bers), 262 clusters were identiﬁed and divided into 141 potential resistance genes
protein families (Table 1). This corresponds to 8% of the total clusters in the data set.
This “strict” selection pattern is very restrictive: if any of the other cluster genes have
a homolog anywhere in the genome, the cluster will be ﬁltered away. Many clusters
contain tailoring enzymes with common functions, such as P450 or methyltransferases;
these can be thought of as “household” functions in secondary metabolism. Clusters
with common tailoring functions will frequently have several homologs, resulting in
high homology counts, and the cluster will therefore fall out of the strict selection
pattern, which may not be what the user wants. Another effect of the ﬁltering is that
the selected clusters often contain fewer genes (average size of 6.4 genes versus 8.2
genes for the total data set). The larger the cluster, the more likely it is that there are
several genes with homologs in the genome. It is likely that clusters containing
potential resistance genes are missed due to the strict selection criteria. Conversely, the
share of bioactive clusters is increased after the selection.
Alternative cluster selection pattern.We wanted to create an alternative selection
pattern to allow the presence of more tailoring enzymes and larger cluster sizes. As a
method to do this, we added an analysis of the genes in the clusters. The most common
InterPro domains (annotated in at least 1,000 cluster genes) were selected, the protein
families belonging to each InterPro domain were identiﬁed, and the sizes of the protein
families were noted. Here, we see that in our data set, the protein families belonging
to each InterPro domain range in size from 1 to 475 proteins (Fig. S1).
When protein families with several homologs in each organism appear in a cluster,
the cluster will be discarded using the strict selection pattern. To avoid this, an
“alternative” selection pattern was created to disregard large protein families as po-
tential resistance genes and instead allow the proteins belonging to large protein
families to have homologs in the organism (Fig. 2, step 2, right).
The size of the protein families will change depending on the data (e.g., the number
of genomes included and how closely related the species are). The selection was
therefore designed to be dependent on the number of organisms in the data set: if the
protein family is larger than the total number of organisms in the data set multiplied
by X, where X is a user input, then the gene is ignored as a potential resistance gene;
e.g., if X is set to 2, the cutoff would be 2 times 5 organisms (Fig. 2, step 2). As the
protein family illustrated has 11 members, it would be allowed in the pattern. If a value
of 3 is selected, the cutoff would be 12, and the illustrated protein family is not large
enough and this cluster would be eliminated.
In our test set, we used a value of 2 or 3 as the user input (X), thereby disregarding
protein families with more than 102 or 153 members, respectively. With these selection
TABLE 1 Number of cases after each ﬁltering step using various settingsa
Step
No. of cases
Strict
Alternative
(X 2)
Alternative
(X 3)
2 141 255 202
3 45 88 67
4 19/14 38/25 32/22
4* 70/43 99/57 89/54
5 6/4 22/15 12/8
5* 31/16 59/33 41/22
aThe columns represent three different cluster selection criteria at step 2, where “Strict” is the most
conservative and “Alternative” (X 2 and X 3) is where the protein families are larger than 2 or 3 times
the total number of organisms allowed in the cluster but not considered potential resistance genes. The
rows represent each of the steps in the pipeline, and * indicates that step 3 was skipped. After step 4, the
two numbers indicate that the resistance protein family has to have homologs in 90%/98% of the
organisms in the data set in step 4.
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criteria, 482 clusters (X 2) and 388 clusters (X 3) are identiﬁed, respectively, corre-
sponding to 84% and 48% increases compared to the initial strict selection criteria
(Table 1). Across these clusters, there are 255 and 202 different potential resistance
gene families, corresponding to increases of 81% and 43%, respectively, showing that
the strict measurement is indeed sensitive to large protein families.
Step 3: ﬁltering for resistance genes found in more than one cluster. A ﬁltering
step is implemented in order to mitigate cluster prediction errors (Fig. 2, step 3). Cluster
prediction algorithms are sensitive to the surrounding genes, but the inclusion of
multiple genomes mitigates this problem. Therefore, we have included the option for
FRIGG to return only clusters where at least one other identiﬁed cluster has a potential
resistance gene belonging to the same protein family. Thereby, the members of the
potential resistance gene protein family have to be found in at least two clusters, across
multiple genomes.
Using these ﬁltering criteria, 45, 88, and 67 of the previously identiﬁed potential
resistance gene protein families are left for the strict pattern, the alternative pattern
where X equals 2, and the alternative pattern where X equals 3, which correspond to
32 to 35% of the initial selected potential resistance gene cases (Table 1). As this is
conservative, we have allowed for the user to skip this step.
Step 4: ﬁltering for clusters targeting essential proteins. It is an underlying
assumption that the target of the compound produced by the cluster should prefer-
entially have an essential function, and thus, it should have protein members in all the
species. By extension, the protein family in which the resistance proteins are found
should therefore also be found in all genomes in the set. Here, we employ this
deﬁnition of essential (present in all genomes) to allow for uncharacterized essential
genes.
The addition of a ﬁltering step to eliminate clusters where the resistance gene is not
duplicating an essential protein family has two purposes: ﬁrst, it makes it more likely
that it is a resistance gene if there are homologs in all species, and second, it will be a
more widely useful bioactive compound if the target is conserved in many species.
The implementation of the ﬁltering step removes clusters where the putative
resistance genes have homologs in fewer than 90 to 100% of the organisms (Fig. 2, step
4). The possibility of choosing values lower than 100% was implemented to allow for
some data and prediction errors, such as incomplete genomes and imperfect gene
annotations. Another reason for choosing a value lower than 100% is to allow some
species to have a different mechanism and, thus, not the target gene.
We examined the effects of selecting 98% and 90% of the genomes (Table 1, step
4). Overall, the numbers of predicted resistance genes drop considerably, to fewer than
one-half of those in step 3 with a 90% cutoff and fewer than one-third with a 98%
cutoff.
As mentioned above, step 3 is conservative and optional. If step 3 is skipped and the
essentiality ﬁlter is applied (Table 1, step 4*), fewer than half are retained for the 90%
cutoff and around one-fourth are retained for the 98% cutoff.
Step 5: ﬁltering the number of organisms with single copies. The ﬁnal ﬁltering
step is related to the organisms in which the putative resistance genes have homologs.
The assumption here is that the target gene should be a single essential gene and,
therefore, that the majority of the species should have only a single copy.
This ﬁltering step therefore removes protein families where more than 50% of the
genomes have more than one homolog of the putative resistance gene (Fig. 2, step 5).
This step is also optional. The effect of adding this selection criteria can be seen in
Table 1 (steps 5 and 5*).
Pipeline output. The primary output of this pipeline is a list of protein families with
potential resistance genes and fasta ﬁles containing all the proteins belonging to the
identiﬁed family. The header of each entry includes the name of the organism, the
section to which it belongs, the protein identiﬁcation, the number of copies found in
the organism, and whether it is in a selected cluster (StrictClust), a predicted cluster
Kjærbølling et al.
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(Clust), or somewhere else in the genome (0), which is followed by the amino acid
sequence.
If high experimental capacity is available, one option is to test all these cases; if the
experimental capacity is limited, further analysis is needed to evaluate and select which
cases to work with. In this example, with 51 species, we obtain 12 different outputs after
step 5 using each of the various settings (Table 1). Starting from 3,276 clusters, we
compare the outputs of all 12 settings and can combine them into 72 unique putative
resistance gene families (Table S2). Four of these are found in every analysis, while 19
are found only once using a speciﬁc set of variables.
With each ﬁltering step, the number of clusters and putative resistance genes
decreases, but the share of likely bioactive clusters and resistance genes increases.
Computer-assisted curation for potential bioactive clusters. Even with the
above-described selection criteria, the pipeline still produces more candidate clusters
than would be feasible for most academic laboratories to verify experimentally. Once
the pipeline has been run and potential resistance gene cases have been identiﬁed,
further analysis is needed to select the most promising candidates for experimental
veriﬁcation.
In order to do this efﬁciently, we use a combination of principal-component analysis
(PCA), phylogenetic analysis, functional annotation, and comparison to the NCBI data-
base using BLASTp in order to gain more knowledge about the potential cases
(examples of the PCA and phylogenetic trees can be seen in Fig. 3 and in Fig. S2 and
S3 in the supplemental material).
The functional annotation and BLAST analysis are included to examine whether a
potential resistance gene has a known function, if the function is essential, and if it
would be a good drug target.
The PCA and phylogenetic trees are used to illustrate the evolutionary relationship
between the proteins in the protein family. Resistance genes are expected to be a
duplication of a target gene that is essential. Essential genes are under similar evolu-
tionary pressures in all the species and are therefore closely related. The resistance
gene, however, is under a different selection pressure, potentially expressed under a
different subset of conditions, which is expected to be reﬂected in the sequence and,
hence, the analysis, where resistance genes should form a separate group in the PCA
or a separate clade in the tree compared to the target genes.
Another thing which can be considered is the synteny of the clusters, whether the
order and functions of the genes are conserved when comparing clusters identiﬁed in
two species. This can be used to evaluate cluster borders and similarity, but it requires
at least two species to have similar clusters, which is not always the case.
Examination of veriﬁed clusters. As mentioned in the introduction, there are some
known clusters in fungi containing a veriﬁed resistance gene using this mechanism.
These include the mycophenolic acid cluster in P. brevicompactum and the fellutamide
B cluster from A. nidulans. Both clusters were included in this study as validation
controls to check if the known resistance genes would be identiﬁed using our pipeline.
The fellutamide B cluster is identiﬁed in all the outputs where step 3 was skipped,
since this was the only cluster with this resistance gene and the selected homology
count pattern. Thus, when ﬁltering for replication of the pattern (step 3), it falls out of
the analysis.
One hypothesis was that the potential resistance and target genes are exposed to
different evolutionary pressures. This is expected to be reﬂected in the evolutionary
pattern, where the essential target genes (under high pressure) will be closely related,
whereas the resistance genes will show more variation. To investigate if this is the case,
and to provide an example of the curation process, a phylogenetic tree and a PCA were
performed for the protein family containing the fellutamide B resistance gene (protein
family 596635) (Fig. 3). The PCA shows a clear distinction between the resistance genes
found in clusters (Fig. 3B, red) and the other essential target genes (Fig. 3B, blue). The
phylogenetic tree (Fig. 3A) shows two clear groupings: one large closely related group
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with all the target genes (blue) and one small group containing the resistance gene
(red). The target genes are ordered in their phylogenetic groups, so species from the
same section group together. The resistance gene from A. nidulans is grouped with a
protein from Aspergillus sydowii and A. versicolor, both of which are found in clusters,
indicating that they most likely also function as resistance genes and potentially can
produce fellutamide B or a derivative or a different compound attacking the same
target. A. versicolor is known to produce fellutamides C and F (22, 23), whereas A.
sydowii, to our knowledge, has not been reported to produce derivatives of fellutamide.
The clusters in A. versicolor and A. sydowii are similar to the A. nidulans fellutamide B
cluster, with similar backbone enzymes (70%) and tailoring enzymes, but the A.
versicolor and A. sydowii predicted clusters are larger, consisting of 19 genes, 7 more
than in the A. nidulans cluster. Three of the extra genes have homologs in the genome
and belong to small protein families, which is why these clusters are not identiﬁed in
the ﬁrst steps of the pipeline.
A.luchuensis CBS 106.47 Nigri 209832 c1 0
A.aculeatinus Nigri 469317 c1 0
A.brasiliensis Nigri 197465 c1 0
A.brunneoviolaceus Nigri 387781 c1 0
A.campestris Candidi 252735 c1 0
A.carbonarius Nigri 165128 c2 0
A.clavatus Clavati 3611 c1 0
A.ellipticus Nigri 398874 c1 0
A.eucalypticola Nigri 349495 c1 0
A.flavus Flavi 30126 c1 0
A.fumigatus A1163 Fumigati 106192 c1 0
A.fumigatus Fumigati 7720 c1 0
A.glaucus Aspergillus 23276 c1 0
A.heteromorphus Nigri 339916 c1 0
A.homomorphus Nigri 432932 c2 0
A.homomorphus Nigri 446020 c2 0
A.niger (lacticoffeatus) Nigri 367344 c1 0
A.nidulans Nidulantes 2700 c2 StrictClust
A.nidulans Nidulantes 10077 c2 outsideSC
A.novofumigatus Fumigati 440350 c1 0
A.ochraceoroseus Ochraceorosei 482263 c1 0
A.saccharolyticus Nigri 361181 c1 0
A.sclerotiicarbonarius Nigri 338122 c1 0
A.sclerotioniger Nigri 538202 c1 0
A.steynii Circumdati 466353 c1 0
A.sydowii Nidulantes 88228 c2 0
A.sydowii Nidulantes 214207 c2 Clust
A.terreus Terrei 1552 c1 0
A.uvarum Nigri 296933 c1 0
A.versicolor Nidulantes 29515 c2 0
A.versicolor Nidulantes 43421 c2 Clust
A.violaceofuscus Nigri 351876 c1 0
A.wentii Cremei 108301 c1 0
A.fijiensis Nigri 394791 c1 0
A.ibericus Nigri 387552 c1 0
A.japonicus Nigri 359166 c1 0
N.fischeri Fumigati 9549 c1 0
E.ruber Aspergillus 414318 c1 0
P.brevicompactum AgRF18 Penicillium 385821 c1 0
A.taichungensis Candidi 183784 c2 0
A.taichungensis Candidi 191932 c2 0
A.welwitschiae Nigri 54871 c1 0
A.indologenus Nigri 499574 c1 0
A.candidus CBS 102.13 Candidi 50619 c2 0
A.candidus CBS 102.13 Candidi 122966 c2 0
A.aculeatus Nigri 28146 c1 0
A.carbonarius Nigri 205711 c2 0
A.neoniger Nigri 368816 c1 0
A.niger ATCC 1015 Nigri 1179469 c1 0
A.niger CBS 513.88 Nigri 169108 c1 0
A.oryzae Flavi 2724 c1 0
A.niger (phoenicis) Nigri 322383 c1 0
A.piperis Nigri 408898 c1 0
A.tubingensis Nigri 37227 c1 0
A.vadensis Nigri 433360 c1 0
A.luchuensis IFO 4308 Nigri 19694 c1 0
A.costaricaensis Nigri 291344 c1 0
A.elegans Circumdati 296129 c1 0
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FIG 3 Phylogenetic tree and principal-component analysis of protein family 596635, including the fellutamide B resistance gene. (A) Phylogenetic tree of the
protein family (596635) containing the fellutamide B resistance gene (protein identiﬁcation 2700) from A. nidulans. The phylogenetic tree is a maximum
likelihood tree and was created with 500 bootstraps. (B) Principal-component analysis of protein family 596635 containing the fellutamide B resistance gene
(protein identiﬁcation 2700) from A. nidulans. The panels to the left are colored based on the sections to which the proteins belong, while the panels to the
right are colored based on if the protein is a putative resistance gene (StrictClust), in a predicted cluster (Clust), a target not in a cluster (0), and the homolog
to the putative resistance gene (putative target) (outsideSC).
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Near the resistance genes in the phylogenetic tree, there are also three other genes,
found in Aspergillus homomorphus, A. taichungensis, and A. candidus, which are extra
copies of the target genes, but they are not predicted to be in clusters. These could be
cluster prediction errors. We therefore investigated whether the three species have a
cluster similar to the A. nidulans fellutamide B cluster, but no backbone genes had a
BLASTp hit identity of 37%, indicating that they most likely cannot produce any
derivatives of fellutamide. Another explanation for the extra copy could be that it
functions in fellutamide resistance, which could be useful if the species naturally grow
near fellutamide-producing species.
The cluster of mycophenolic acid did not turn up in our outputs, so we investigated
the cluster further to understand why. The predicted cluster containing the polyketide
synthase (PKS) responsible for producing the core compound of mycophenolic acid
consists of four genes: the PKS, a P450, a methyltransferase, and the resistance gene.
The PKS and p450 are found in only one copy, and the resistance gene has one
identiﬁed homolog, as expected. The methyltransferase, however, also has a homolog
elsewhere in the genome. As the size of this protein family is only 23 members, it is not
disregarded in the alternative pattern, and the cluster is ﬁltered away in step 2. This
shows that we lose some correct cases along the steps in the pipeline, which illustrates
the importance of running the pipeline with multiple settings and inspecting the
output carefully. The pipeline is sensitive to the number of organisms included, and the
settings should be used while keeping this limitation in mind.
Novel putative resistance gene. In addition to the known clusters with resistance
genes, several uncharacterized clusters were also identiﬁed. Here, we focus on one
example where the potential resistance gene is found in clusters in A. oryzae (protein
identiﬁcation 11595) and A. ﬂavus (protein identiﬁcation 32200) (protein family 597268).
The PCA showed a very clear picture of the resistance genes falling outside the group
of target genes; the same is seen in the phylogenetic tree, where the target genes also
follow the expected phylogeny, with species from the same section grouping together
(Fig. S2 and S3). Besides the identiﬁed putative resistance genes in Aspergillus oryzae
and A. ﬂavus, several other species (Aspergillus wentii, A. piperis, A. candidus, A. taichun-
gensis, A. campestris, A. novofumigatus, and P. brevicompactum) have an additional
gene, but these are not found in predicted clusters, suggesting that they have the
resistance but not the biosynthesis.
The predicted clusters in A. oryzae and A. ﬂavus both consist of four genes: an
acetyltransferase (InterPro accession numbers IPR000182 and IPR016181), the predicted
resistance gene, a nonribosomal peptide synthetase-like synthetase, and a gene be-
longing to the major facilitator superfamily (InterPro accession number IPR011701). The
putative resistance gene has annotations involved in “signal transduction response
regulator, receiver region,” and “signal transduction histidine kinase, core” (InterPro
accession numbers IPR001789 and IPR005467). Using BLASTp to investigate the func-
tion of the putative resistance gene, the top hits have functions such as “two-
component osmosensing histidine kinase (Bos1)” (GenBank accession number
RAQ55620.1). Based on this information, it seems likely that this is a cluster containing
a previously unidentiﬁed resistance gene where the compound inhibits a conserved
histidine kinase. In order to fully determine this, this will have to be experimentally
validated in the future.
DISCUSSION
The pipeline was designed to identify secondary metabolite gene clusters (clusters)
containing potential resistance genes. It is a delicate balance of ﬁltering away as many
clusters as possible to narrow down the ﬁeld to the best candidates while keeping as
many clusters with potential resistance genes as possible.
We have chosen an approach where we make no assumptions about the function
or makeup of resistance genes besides being homologs of a gene shared by most
organisms in the data set (a mock measure for essentiality). Another approach could be
to screen for speciﬁc classes of essential genes or resistance targets within predicted
Resistance Gene-Directed Genome Mining in Aspergillus
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clusters. This approach was used in another study where 86 bacterial Salinispora
genomes were mined for duplicated genes involved in central metabolism colocalizing
with clusters. Clusters containing putative fatty acid synthase resistance genes were
identiﬁed, and these were shown to be involved in the biosynthesis of thiotetronic acid
natural products, including thiolactomycin, which is a well-known fatty acid synthase
inhibitor (24). This approach builds on knowledge of housekeeping genes, thus requir-
ing extensive knowledge of the primary metabolism. In ﬁlamentous fungi, there are still
many uncharacterized genes; therefore, there is a risk of missing interesting resistance
genes using that approach. To avoid this, we chose to use a wider approach based only
on the homology copy number pattern of predicted secondary metabolism genes and
not on the functions. The underlying assumption is that our pipeline identiﬁes con-
served household genes with a homolog in a cluster. Using our approach, we avoid
limiting the search space to only known mechanisms, thereby making it possible to ﬁnd
new essential mechanisms and drug targets. Our non-function-impelled approach can
be used on organisms with both little and extensive available knowledge. Finally, the
setup makes it possible to search the identiﬁed clusters afterwards with a criterion such
as the presence of primary metabolism genes. The pipeline has been designed for a
speciﬁc data setup, but it is equally possible to apply the approach to other data sets.
In applying the pipeline, it is important to select the input data carefully. Genomes
from very distantly related species might not give meaningful homologous protein
families using our cutoffs, since proteins with similar functions might be more different
than our cutoffs allow. Step 1 in the pipeline combines the input data and creates a
table of homology counts for all cluster genes in the input set. In this step, no ﬁltering
or selection is done, and hence, there are no parameters to tweak.
In step 2, strict or alternative patterns for the cluster homology counts can be
selected. Using the strict selection criteria, only 8% of the clusters meet the criteria.
When using selection patterns that are too restrictive, there is a risk of creating
false-negative results, thus ﬁltering away good cases. As mentioned above, many
common secondary metabolite genes are likely to have homologs and belong to large
protein families. Of the cluster genes belonging to this test data set, 12% and 6%
belong to protein families larger than 102 and 153 proteins, respectively, and notably,
these are found in 51% and 37% of the total clusters. Thus, using the strict selection
pattern, up to one-half of the clusters are likely to be discarded due to the homology
count pattern of standard cluster genes, which is highly conservative and can cause
false-negative results. We therefore recommend the use of the alternative selection
pattern. If the species in the data set are distantly related, the size of the protein families
might be smaller, and therefore, a lower Xinput is recommended. The lowest value of
Xinput that we recommend is 1.5; when using a lower value, the risk of disregarding true
resistance gene families becomes very high.
Step 3, ﬁltering for more than one cluster having the putative resistance gene, was
designed to avoid false-positive results due to cluster prediction errors. This step is
useful for data that include closely related species likely to have similar clusters. If the
data consist mainly of distantly related species, it is less likely that similar clusters will
be found in more species, and hence, the risk of ﬁltering away good cases increases,
thereby making false-negative results. In the test data, about two-thirds of the cases are
ﬁltered away in this step. If running the pipeline and more than two-thirds are ﬁltered
away, we suggest skipping this step. With distantly related species, we suggest always
skipping this step.
Step 4 was made to avoid false-positive results, by checking that the resistance gene
is a homolog of an essential gene. One can set the percentage of species required to
have the homolog. If the species are distantly related, it is more likely that some species
have a different essential household mechanism and hence do not have a copy of the
household/target gene. A lower percentage of organisms that should have a homolog
is thus recommended in this case. Another reason for choosing a lower percentage is
when the quality of the genome sequence data is low, with incomplete genomes, or
when the data include novel species distantly related to model organisms, where the
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gene prediction algorithms might not work as efﬁciently. In these cases, absent
homologs could be false-negative results and should thus be allowed for.
Step 5 was also added to avoid false-positive results; in this step, at least 50% of the
species should have only a single homolog. This ﬁltering step is independent of the
quality of the data and the relatedness of the species, and we therefore recommend
using this at all times. Here, 30 to 60% of the cases are left after this ﬁltering.
In the future, it could be interesting to investigate the transcription of target and
resistance genes in order to investigate if there are differences in expression patterns
and if these can be applied in the search.
Conclusions. In this study, we have created a method to identify clusters respon-
sible for producing bioactive compounds. The approach that we have developed is
based on a speciﬁc resistance mechanism and paves the way for rational selection of
promising bioactive clusters from whole-genome data. The FRIGG pipeline was de-
signed for relatively closely related fungal genomes; however, several ﬁltering steps
and parameters can be tweaked to ﬁt different kinds of data and to deal with the most
likely errors from predictions and draft genomes.
We have tested the developed pipeline on 51 Aspergillus and Penicillium genomes,
using various settings. By applying these settings, we identiﬁed 72 unique putative
resistance genes and clusters in total. In addition, the previously characterized fellut-
amide B resistance gene inpE was successfully identiﬁed with this pipeline, conﬁrming
the accuracy and applicability of the pipeline to such cases of resistance mechanisms.
As more and more genomes are sequenced, the relevance of this approach will
increase, and it will become a useful method for selecting which clusters to focus on in
the hunt for novel drugs such as antifungals, anticancer drugs, and antimicrobial
compounds.
MATERIALS AND METHODS
Fungal species. The data consisted of 50 Aspergillus and 1 Penicillium species with available
whole-genome sequencing data, which were downloaded from the JGI database (5, 6, 25). Species
information, including GenBank accession numbers, can be found in Table S1 in the supplemental
material.
Input data. All data are stored as csv/sql ﬁles in a folder on Zenodo and can be found at
https://doi.org/10.5281/zenodo.2560245. The data used in the pipeline were organized in a MySQL
database; an overview of the input data can be found in the ﬁle Input_data_pipeline.txt. The data include
predicted secondary metabolite gene clusters based on an implementation of the SMURF pipeline (21)
described previously (6). Homologous protein families were created with Aspergillus-optimized param-
eters based on single linkage of bidirectional BLASTp hits with an identity of 50% and a sum of query
and hit coverage of 130%, as described previously (6). InterPro annotations of the proteins (19, 20) and
gff information were also used.
Pipeline. All scripts and additional information ﬁles are available at Zenodo (https://doi.org/10.5281/
zenodo.2560245). The pipeline was created using Python, and the investigation of speciﬁc protein
families was conducted in R (26). The versions and packages used can be seen in version information ﬁles.
For alignment of sequences of the protein families, clustalo (27) was used, and sequences were trimmed
with Gblocks (28, 29) using a Python script, also included in the folder. A readme ﬁle describes the various
steps in the pipeline, including the inputs, outputs, how to run them, and which parameters can be
changed. The ﬁrst step of the pipeline is the most time-consuming, combining the protein families and
the SMURF data to create “homology count” data, which takes approximately 7 h on a standard desktop
computer for the data used here. The following selection and ﬁltering steps take 8 to 40 min, depending
on the parameters used.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mSystems.00085-19.
FIG S1, PDF ﬁle, 0.2 MB.
FIG S2, PDF ﬁle, 0.7 MB.
FIG S3, PDF ﬁle, 0.2 MB.
TABLE S1, CSV ﬁle, 0.1 MB.
TABLE S2, CSV ﬁle, 0.1 MB.
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